| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.47 | 0.0009 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |